Evidence map›Paper›PMID 37723971›Full record

ArticleeLife2023

Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART.

Oscar Blanch-Lombarte, Dan Ouchi, Esther Jimenez-Moyano, Julieta Carabelli, Miguel Angel Marin, Ruth Peña, Adam Pelletier, Aarthi Talla, Ashish Sharma, Judith Dalmau and 4 more

Abstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Oscar Blanch-LombarteIrsiCaixa AIDS Research Institute, Barcelona, Spain.ORCID 0000-0002-8317-7535
Dan OuchiIrsiCaixa AIDS Research Institute, Barcelona, Spain.
Esther Jimenez-MoyanoIrsiCaixa AIDS Research Institute, Barcelona, Spain.
Julieta CarabelliIrsiCaixa AIDS Research Institute, Barcelona, Spain.
Miguel Angel MarinIrsiCaixa AIDS Research Institute, Barcelona, Spain.ORCID 0000-0001-5294-6007
Ruth PeñaIrsiCaixa AIDS Research Institute, Barcelona, Spain.
Adam PelletierPathology Department, Case Western Reserve University, Cleveland, United States.
Aarthi TallaPathology Department, Case Western Reserve University, Cleveland, United States.
Ashish SharmaPathology Department, Case Western Reserve University, Cleveland, United States.
Judith DalmauIrsiCaixa AIDS Research Institute, Barcelona, Spain.
José Ramón SantosLluita contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
Rafick-Pierre SékalyPathology Department, Case Western Reserve University, Cleveland, United States.
Bonaventura ClotetIrsiCaixa AIDS Research Institute, Barcelona, Spain.
Julia G PradoIrsiCaixa AIDS Research Institute, Barcelona, Spain.ORCID 0000-0002-5439-4645

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The co-expression of inhibitory receptors (IRs) is a hallmark of CD8+ T-cell exhaustion (Tex) in people living with HIV-1 (PLWH). Understanding alterations of IRs expression in PLWH on long-term antiretroviral treatment (ART) remains elusive but is critical to overcoming CD8+ Tex and designing novel HIV-1 cure immunotherapies. To address this, we combine high-dimensional supervised and unsupervised analysis of IRs concomitant with functional markers across the CD8+ T-cell landscape on 24 PLWH over a decade on ART. We define irreversible alterations of IRs co-expression patterns in CD8+ T cells not mitigated by ART and identify negative associations between the frequency of TIGIT+ and TIGIT+ TIM-3+ and CD4+ T-cell levels. Moreover, changes in total, SEB-activated, and HIV-1-specific CD8+ T cells delineate a complex reshaping of memory and effector-like cellular clusters on ART. Indeed, we identify a selective reduction of HIV-1 specific-CD8+ T-cell memory-like clusters sharing TIGIT expression and low CD107a that can be recovered by mAb TIGIT blockade independently of IFNγ and IL-2. Collectively, these data characterize with unprecedented detail the patterns of IRs expression and functions across the CD8+ T-cell landscape and indicate the potential of TIGIT as a target for Tex precision immunotherapies in PLWH at all ART stages.

Indexed as

HIV-1Anti-Retroviral AgentsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesHumansReceptors, ImmunologicAnti-Retroviral AgentsReceptors, ImmunologicTIGIT protein, humanCD107aHIV-1-specific CD8+ T cellsimmunologyinflammationinhibitory receptorspeople living with HIV-1single-cell CD8+ dynamicsTIGITviruses

Identifiers

PMID37723971
PMCPMC10508883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.